Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction

References

Page 1

	Year	Citations
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction Marcus A. DeWood, Julie Spores, Robert N. Notske, New England Journal of Medicine Fogarty CatheterTransmural Myocardial InfarctionCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1980	2.7K
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. James H. Chesebro, Genell L. Knatterud, Robert Roberts, Circulation ThrombosisHospital DischargeCardiovascular DiseaseIntravenous StreptokinaseAtherosclerosis	1987	2.2K
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION Anders Hamsten, Göran Walldius, Alfred Szamosi, The Lancet ThrombosisCardiovascular DiseaseMedicineCardiologyPharmacotherapy	1987	1.5K
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction Anders Hamsten, Björn Wiman, Ulf dé Fairé, New England Journal of Medicine ThrombosisHeart FailureFibrinolytic ActivityHealthy SubjectsCardiovascular Disease	1985	1.4K
Plasminogen activator inhibitors E.D. Sprengers, C Kluft Blood	1987	930
Plasminogen activator inhibitors E.D. Sprengers, Cornelis Kluft Blood Plasminogen Activator InhibitorsMedicineMechanism Of ActionPharmacological AgentPharmacotherapy	1987	780
RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION M Verstraete, M Bory, D Collen, The Lancet ThrombosisCardiovascular DiseaseFibrinolysisCardiologyPharmacotherapy	1985	752
Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* J. H. Chesebro, Genell L. Knatterud, Robert Roberts, ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisAcutemyocardial Infarction	1987	735
Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase Dwight Peake Journal of Emergency Medicine ThrombosisIntravenous StreptokinaseCardiovascular DiseaseFibrinolysisCardiology	1988	534
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke Felicita Andreotti, Graham J. Davies, David Hackett, The American Journal of Cardiology ThrombosisSleepHeart FailureAlertnessCardiovascular Disease	1988	427

Page 1